Allergan Inc. (AGN) Posts Flat Q3 Profit, Ponders Selling Fat Biz  
10/30/2012 7:07:51 AM

Allergan Inc.'s (AGN) third-quarter earnings edged down slightly as the maker of Botox and medical devices posted more one-time items, masking continued sales growth for top drug Botox.

Since the end of the quarter, Allergan said it is exploring strategic options for its obesity intervention business, including among other things, a potential sale of the unit.